Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Giuffrida

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Biomolecules|September 27, 2025
Single-Vesicle Molecular Profiling by dSTORM Imaging in a Liquid Biopsy Assay Predicts Early Relapse in Colorectal CancerGabriele Raciti, Giulia Cavallaro, Raffaella Giuffrida, et al.
Journal of Translational Medicine|October 15, 2024
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutationPiera Grisolia, Rossella Tufano, Clara Iannarone, et al.
Frontiers in Pharmacology|January 18, 2024
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor <i>in vivo</i> acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncologyIméne Ben Toumia, Tiziana Bachetti, Leila Chekir-Ghedira, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detectionAntonio De Falco, Piera Grisolia, Raffaella Giuffrida, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Biomolecules|September 27, 2025
Single-Vesicle Molecular Profiling by dSTORM Imaging in a Liquid Biopsy Assay Predicts Early Relapse in Colorectal CancerGabriele Raciti, Giulia Cavallaro, Raffaella Giuffrida, et al.
Journal of Translational Medicine|October 15, 2024
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutationPiera Grisolia, Rossella Tufano, Clara Iannarone, et al.
Frontiers in Pharmacology|January 18, 2024
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor <i>in vivo</i> acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncologyIméne Ben Toumia, Tiziana Bachetti, Leila Chekir-Ghedira, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detectionAntonio De Falco, Piera Grisolia, Raffaella Giuffrida, et al.
Pageof 4